Predictive models used for screening of fragments, de-novo designed compounds and our large privileged compound collection to identify series of hits for all classes of targets.
Mapping of interactions to potency
On-target screening
Pharmacophore/QSAR/Docking models
Screening of large virtual databases
Identification of hits and compound design
Hit quality assessment through preliminary filters